[The Multiple Sclerosis Health Resource Utilization Survey].

Nils-Henning Ness Dirk Schriefer Rocco Haase Tjalf Ziemssen

Published in: Fortschritte der Neurologie-Psychiatrie (2021)

Valid cost data bring transparency to the economic consequences of diseases. In addition to clinical data, cost data can be used to determine cost-effectiveness and thus reveal opportunities for more efficient patient care. For the case of MS, a freely accessible tool is available for cost assessments.

Keyphrases

multiple sclerosis
electronic health record
big data
healthcare
public health
mass spectrometry
mental health
ms ms
cross sectional
gene expression
risk assessment
single cell
artificial intelligence
health promotion